BioXcel Therapeutics Inc (BTAI)
2.09
+0.03
(+1.46%)
USD |
NASDAQ |
May 16, 16:00
2.075
-0.02
(-0.72%)
After-Hours: 20:00
BioXcel Therapeutics Shareholders Equity (Quarterly): -72.36M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -72.36M |
December 31, 2023 | -56.51M |
September 30, 2023 | -40.61M |
June 30, 2023 | 5.864M |
March 31, 2023 | 53.00M |
December 31, 2022 | 76.78M |
September 30, 2022 | 126.99M |
June 30, 2022 | 164.26M |
March 31, 2022 | 194.02M |
December 31, 2021 | 221.67M |
September 30, 2021 | 245.56M |
June 30, 2021 | 267.41M |
March 31, 2021 | 186.74M |
Date | Value |
---|---|
December 31, 2020 | 206.70M |
September 30, 2020 | 220.94M |
June 30, 2020 | 53.39M |
March 31, 2020 | 72.59M |
December 31, 2019 | 26.90M |
September 30, 2019 | 34.42M |
June 30, 2019 | 25.16M |
March 31, 2019 | 32.37M |
December 31, 2018 | 38.89M |
September 30, 2018 | 45.82M |
June 30, 2018 | 49.82M |
March 31, 2018 | 52.11M |
December 31, 2017 | -0.982M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-72.36M
Minimum
Mar 2024
267.41M
Maximum
Jun 2021
100.64M
Average
74.68M
Median
Shareholders Equity (Quarterly) Benchmarks
Cormedix Inc | 58.01M |
Bristol-Myers Squibb Co | 16.49B |
Amicus Therapeutics Inc | 130.69M |
Insmed Inc | -464.81M |
InfuSystems Holdings Inc | 52.28M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 82.32M |
Total Liabilities (Quarterly) | 154.69M |
Debt to Equity Ratio | -1.404 |
Current Ratio | 2.570 |
Net Debt Paydown Yield | -1.81% |